Credit Suisse Ag X Biotech Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in X Biotech Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 248,270 shares of XBIT stock, worth $796,946. This represents 0.0% of its overall portfolio holdings.

Number of Shares

248,270

Previous 248,270 -0.0%

Holding current value

$796,946

Previous $993,000 103.22%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$3.56 - $4.65 $10,680 - $13,950	3,000 Added 1.22%	248,270 $993,000
Q4 2022 Feb 13, 2023	SELL	$3.03 - $3.79 $55,867 - $69,880	-18,438 Reduced 6.99%	245,270 $860,000
Q3 2022 Nov 10, 2022	BUY	$3.58 - $5.88 $134,468 - $220,858	37,561 Added 16.61%	263,708 $955,000
Q2 2022 Aug 12, 2022	BUY	$5.13 - $9.2 $360,608 - $646,704	70,294 Added 45.1%	226,147 $1.27 Million
Q1 2022 May 16, 2022	SELL	$8.64 - $11.71 $1,062 - $1,440	-123 Reduced 0.08%	155,853 $1.35 Million
Q4 2021 Feb 14, 2022	BUY	$10.95 - $16.07 $226,675 - $332,665	20,701 Added 15.3%	155,976 $1.74 Million
Q3 2021 Nov 12, 2021	SELL	$12.95 - $18.24 $284,304 - $400,440	-21,954 Reduced 13.96%	135,275 $1.75 Million
Q2 2021 Aug 16, 2021	BUY	$15.83 - $17.84 $1.31 Million - $1.48 Million	82,976 Added 111.75%	157,229 $2.6 Million
Q1 2021 May 14, 2021	BUY	$15.92 - $20.3 $359,935 - $458,962	22,609 Added 43.78%	74,253 $1.28 Million
Q4 2020 Feb 12, 2021	SELL	$15.65 - $19.92 $10,172 - $12,948	-650 Reduced 1.24%	51,644 $808,000
Q3 2020 Nov 13, 2020	BUY	$13.97 - $21.16 $523,413 - $792,801	37,467 Added 252.69%	52,294 $998,000
Q2 2020 Aug 12, 2020	SELL	$10.39 - $16.07 $261,796 - $404,915	-25,197 Reduced 62.95%	14,827 $202,000
Q1 2020 May 13, 2020	BUY	$8.89 - $24.94 $239,861 - $672,906	26,981 Added 206.86%	40,024 $425,000
Q4 2019 Feb 12, 2020	SELL	$8.33 - $19.95 $3,815 - $9,137	-458 Reduced 3.39%	13,043 $244,000
Q3 2019 Nov 12, 2019	BUY	$6.86 - $10.46 $8,815 - $13,441	1,285 Added 10.52%	13,501 $141,000
Q2 2019 Aug 14, 2019	BUY	$6.99 - $11.27 $85,389 - $137,674	12,216 New	12,216 $92,000
Q1 2019 May 14, 2019	SELL	$5.05 - $11.62 $50,631 - $116,502	-10,026 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$3.22 - $6.27 $44,142 - $85,955	-13,709 Reduced 57.76%	10,026 $51,000
Q3 2018 Nov 13, 2018	SELL	$2.31 - $4.69 $56,553 - $114,820	-24,482 Reduced 50.77%	23,735 $76,000
Q2 2018 Aug 14, 2018	SELL	$4.04 - $5.13 $26,744 - $33,960	-6,620 Reduced 12.07%	48,217 $217,000
Q1 2018 May 15, 2018	SELL	$3.92 - $5.35 $929 - $1,267	-237 Reduced 0.43%	54,837 $293,000
Q4 2017 Feb 14, 2018	SELL	$3.9 - $4.66 $84,532 - $101,005	-21,675 Reduced 28.24%	55,074 $216,000
Q3 2017 Nov 14, 2017	BUY	$4.14 - $5.12 $187,086 - $231,372	45,190 Added 143.19%	76,749 $334,000
Q2 2017 Aug 14, 2017	BUY	N/A	31,559	31,559 $149,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.74M

Call Options Held

Put Options Held

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $97.7M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account